19. June 2025
Nabla Secures 70 Million As It Bolsters Leadership In Ai-Powered Healthcare
Nabla, a pioneering healthcare technology company, has secured $70 million in Series C funding, further solidifying its position as a leader in the use of artificial intelligence (AI) in clinical settings. This investment, led by Germany’s HV Capital, brings Nabla’s total raised since its inception in 2018 to a staggering $120 million.
The additional capital is expected to fuel the company’s ambitious plans to expand its AI-powered platform beyond documentation into more comprehensive agentic models of clinical AI. Founded in Paris with an office in New York, Nabla has been steadily making waves in the healthcare industry with its innovative AI copilot, designed to assist doctors and other medical staff.
This cutting-edge technology, which takes notes and writes medical reports on behalf of staff, has already been embedded in over 130 healthcare organizations worldwide. The company’s AI assistant has proven to be a game-changer, significantly reducing clinical documentation time by more than half while also decreasing clinician burnout and boosting patient satisfaction.
The financial backing Nabla has secured is a testament to the growing recognition of the importance of AI in the healthcare sector. According to Crunchbase data, nearly half of U.S. venture funding went to AI-related enterprises over the past year alone. The surge in investment into startups using AI is set to continue, with late-stage deals dominating the landscape and accounting for roughly 61% of all AI-related venture deals.
AI’s global dominance is equally impressive, with $59.6 billion invested in the sector during the first quarter, according to Crunchbase’s global funding report. This staggering figure represents a 53% share of global funding, marking the strongest quarter ever for AI investments.
Nabla’s plans for the additional capital are ambitious and far-reaching. With its new funding, the company aims to build a comprehensive Adaptive Agentic Platform, expanding beyond documentation into more agentic models of clinical AI. This platform will enable healthcare organizations to harness the full potential of AI, providing real-time coding assistance, context-aware agents that surface historical data, and expanded tools for nurses and inpatient teams.
One of the most significant areas of focus for Nabla is developing a real-time coding assistant that flags billing issues and nudges documentation as care happens. This cutting-edge technology is poised to revolutionize clinical documentation processes, freeing up healthcare professionals from tedious administrative tasks and allowing them to concentrate on delivering high-quality patient care.
By leveraging AI’s capabilities in this way, Nabla aims to significantly enhance the overall efficiency of healthcare operations. The company’s innovative approach to clinical AI serves as a compelling example of how technology can drive meaningful change in healthcare.
Nabla’s success story highlights the importance of investing in healthcare startups that harness the power of AI. By supporting innovative companies like Nabla, we can accelerate progress towards a more efficient, effective, and compassionate healthcare system. As the sector continues to evolve, it is essential that we prioritize investment in these groundbreaking solutions, ensuring they reach scale and have a lasting impact on patient care.
The future of healthcare is bright, with AI playing an increasingly vital role in shaping the landscape. Startups like Nabla are leading the charge, driving innovation and pushing the boundaries of what is possible. As we move forward, it will be fascinating to watch how this technology continues to evolve, transforming clinical workflows and improving patient outcomes.
Nabla’s valuation, which was reportedly around $180 million at the time of its $24 million Series B funding in January 2024, provides further insight into the sector’s growth prospects. While Nabla did not disclose its current valuation, this figure suggests that the company is poised for significant expansion and continued success.
As we look to the future, it is clear that AI will play an increasingly vital role in shaping the healthcare landscape. Startups like Nabla are at the forefront of this revolution, driving innovation and pushing the boundaries of what is possible. With $70 million in new funding, Nabla is well-positioned to continue its rapid growth trajectory, delivering cutting-edge solutions that transform clinical workflows and improve patient outcomes.
Nabla’s latest funding round marks an exciting milestone for the company, underscoring the growing recognition of AI’s transformative potential in healthcare. As we move forward, it will be fascinating to watch how this technology continues to evolve and mature, driving meaningful change across the sector.